Thomas Snavely - Concepedia

Author

Thomas Snavely

Also Known As

Thomas C. Snavely, Thomas Snavely

Publications

494

Citations

H-Index

Concepts

All Affiliations

Thomas Snavely is an author at Texas A&M University specializing in medicine, natural sciences, and biochemistry.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	38
2	Natural Sciences	2	2	38
3	Biochemistry	2	2	38
4	Business	1	1	28
5	Management	1	1	28

Thomas Snavely

Publications

494

Citations

H-Index

Page 1

	Year	Citations
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13 Anup Aggarwal, Maloy Kumar Parai, N.D. Shetty, Cell	2017	180
Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice Liam M. Guthrie, Shivatheja Soma, Sai Yuan, Science	2020	169
Photoinduced Membrane Damage of E. coli and S. aureus by the Photosensitizer-Antimicrobial Peptide Conjugate Eosin-(KLAKLAK)2 Gregory A. Johnson, E. Ann Ellis, Hansoo Kim, PLoS ONE	2014	46
Wide-ranging and unexpected consequences of altered Pol II catalytic activity <i>in vivo</i> Indranil Malik, Chenxi Qiu, Thomas Snavely, Nucleic Acids Research	2017	33
Outsourcing and strategic alliances for product development: a case of Banta Digital Group Sameer Kumar, Thomas Snavely Technovation Product DevelopmentManagementBusinessInter-firm CoordinationStrategic Sourcing	2003	28
Wide-ranging and unexpected consequences of altered Pol II catalytic activity in vivo Indranil Malik, Chenxi Qiu, Thomas Snavely, Environmental SignalingPol Ii CatalysisGeneticsMolecular BiologyPol Ii	2016	22
Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of <i>Mycobacterium tuberculosis</i> Adenosine Kinase R.A. Crespo, Qun Dang, Nian Zhou, Journal of Medicinal Chemistry Mtbadok HomodimerStructure-guided Drug DesignTranslational PharmacologyMolecular Pharmacology6-Substituted Adenosine Analogues	2019	16

Page 1